Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Active- (Tramadol and Celecoxib) and Placebo-controlled, Parallel Groups, Phase 3 Clinical Trial to Establish the Efficacy of Co-crystal E-58425 for the Management of Moderate to Severe Post-surgical Pain After Bunionectomy.

NCT03108482 is registered in ClinicalTrials.gov with Esteve Pharmaceuticals, S.A. as lead sponsor.

NCT NCT03108482
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03108482 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Active- (Tramadol and Celecoxib) and Placebo-controlled, Parallel Groups, Phase 3 Clinical Trial to Establish the Efficacy of Co-crystal E-58425 for the Management of Moderate to Severe Post-surgical Pain After Bunionectomy.
Lead sponsor
Esteve Pharmaceuticals, S.A.
Phase
Phase 3
Overall status
Completed
Start date
March 14, 2017
Completion date
November 28, 2017
Enrollment
637 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

acute post-surgical pain